Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.
FDA inspection history in Xuzhou, China, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Xuzhou, China.
Cited most
Across all Fosun Wanbang (Jiangsu) Pharmaceutical Group Co. observations on file
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.192Production record review1
- 21 CFR 211.194Laboratory records1
The complete Fosun Wanbang (Jiangsu) Pharmaceutical Group Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Xuzhou, China
One Form 483 · 2023 · 3 observations
Latest: Form 483, Sep 8, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-09-08 | 483 Form 483 | Xuzhou, China | 3 | $99 |
Investigators on these documents
FEI number 3007836611 · most recent document Sep 8, 2023
About Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.
How many FDA Form 483s has Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.; the most recent is dated Sep 8, 2023.
When was Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. is a Form 483 dated Sep 8, 2023, for the site in Xuzhou, China.
What did FDA cite at Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.?
The regulations cited most in the observations on file for Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.194 (Laboratory records), 1 time.